Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 2.98
2.76 %
$ 52.6 M
Market Cap
-2.92
P/E
Price Target
Average
81.21%
Revenue Forecast
Estimate
15.09%
EBIT
Estimate
--18.54%
Net Income
Estimate
34.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Exagen Inc.
Wall Street analysts predict an average 1-year price target for XGN of $5.4 , with forecasts ranging from a low of $5 to a high of $7 .
XGN Lowest Price Target
Wall Street Target
5 USD
67.79%
XGN Average Price Target
Wall Street Target
5.4 USD
81.21%
XGN Highest Price Target
Wall Street Target
7 USD
134.90%
REVENUE FORECAST
Revenue Forecast Chart XGN
EBIT FORECAST
EBIT Forecast Chart XGN
NET INCOME FORECAST
Net Income Chart XGN